CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Indapamide

吲达帕胺 杂质对照品Indapamide Impurities

EP60 个杂质条目60 impurity entries

本页汇总 吲达帕胺 的 60 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 60 impurity reference standards of Indapamide with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 吲达帕胺(Indapamide)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesStereoselective HPLC separation and configurational stability study of the N-nitrosamine impurity of indapamide
    Journal of chromatography. A · 2026 · Mammone FR et al.  ·  PMID 41420970  ·  DOI
  2. 杂质研究Impurity studiesDevelopment and validation of a stability-indicating assay method for simultaneous determination of perindopril and indapamide in combined dosage form by reversed-phase high-performance liquid chromatography
    Journal of AOAC International · 2010 · Jogia H et al.  ·  PMID 20334172
  3. 杂质研究Impurity studiesUHPLC-UV Method for Simultaneous Determination of Perindopril Arginine and Indapamide Hemihydrate in Combined Dosage Form: A Stability-Indicating Assay Method
    Scientia pharmaceutica · 2018 · Al-Tannak NF  ·  PMID 29470453  ·  DOI
  4. 分析方法Analytical MethodsA Validated HPLC Method for Simultaneous Determination of Perindopril Arginine, Amlodipine, and Indapamide: Application in Bulk and in Different Pharmaceutical Dosage Forms
    Journal of AOAC International · 2017 · El-Bagary RI et al.  ·  PMID 28168948  ·  DOI
  5. 分析方法Analytical MethodsSimultaneous Estimation of Amlodipine Besylate and Indapamide in a Pharmaceutical Formulation by a High Performance Liquid Chromatographic (RP-HPLC) Method
    Scientia pharmaceutica · 2012 · Patel DB et al.  ·  PMID 23008807  ·  DOI

吲达帕胺 —— 原料药与杂质对照品Indapamide — drug substance & impurities

共 60 个条目(含原料药本体)60 items incl. the drug substance
Indapamide Impurity 1(Indapamide EP Impurity A) structure
EPA
吲达帕胺杂质1(吲达帕胺EP杂质A)Indapamide Impurity 1(Indapamide EP Impurity A)
Indapamide Impurity 1(Indapamide EP Impurity A)
CAS No.85440-79-5
Chemical FormulaC9H10N2O
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 2 (Indapamide EP Impurity B) structure
EPB
吲达帕胺杂质2 (吲达帕胺EP杂质B)Indapamide Impurity 2 (Indapamide EP Impurity B)
Indapamide Impurity 2 (Indapamide EP Impurity B)
CAS No.63968-75-2
Chemical FormulaC16H14ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 5 (Indapamide EP Impurity C) structure
EPC
吲达帕胺杂质5 (吲达帕胺EP杂质C)Indapamide Impurity 5 (Indapamide EP Impurity C)
Indapamide Impurity 5 (Indapamide EP Impurity C)
CAS No.31529-46-1
Chemical FormulaC9H12N2
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 5 Hydrochloride (Indapamide EP Impurity C Hydrochloride) structure
EPC
吲达帕胺杂质5 盐酸盐 (吲达帕胺EP杂质C 盐酸盐)Indapamide Impurity 5 Hydrochloride (Indapamide EP Impurity C Hydrochloride)
Indapamide Impurity 5 Hydrochloride (Indapamide EP Impurity C Hydrochloride)
CAS No.31529-47-2
Chemical FormulaC9H12N2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 5 Mesylate (Indapamide EP Impurity C Mesylate) structure
EPC
吲达帕胺杂质5 甲磺酸盐 (吲达帕胺EP杂质C 甲磺酸盐)Indapamide Impurity 5 Mesylate (Indapamide EP Impurity C Mesylate)
Indapamide Impurity 5 Mesylate (Indapamide EP Impurity C Mesylate)
CAS No.85392-00-3
Chemical FormulaC9H12N2·CH4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 3 structure
3
吲达帕胺杂质3Indapamide Impurity 3
Indapamide Impurity 3
CAS No.70049-77-3
Chemical FormulaC7H5Cl2NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 4 structure
4
吲达帕胺杂质4Indapamide Impurity 4
Indapamide Impurity 4
CAS No.126750-70-7
Chemical FormulaC16H16ClN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 6 structure
6
吲达帕胺杂质6Indapamide Impurity 6
Indapamide Impurity 6
CAS No.2457316-06-0
Chemical FormulaC16H15ClN2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 7 structure
7
吲达帕胺杂质7Indapamide Impurity 7
Indapamide Impurity 7
CAS No.1205-30-7
Chemical FormulaC7H6ClNO4S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 8 structure
8
吲达帕胺杂质8Indapamide Impurity 8
Indapamide Impurity 8
CAS No.6872-06-6
Chemical FormulaC9H11N
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 10 (Sulclamide) structure
10
吲达帕胺杂质10(氨磺氯苯酰胺)Indapamide Impurity 10 (Sulclamide)
Indapamide Impurity 10 (Sulclamide)
CAS No.2455-92-7
Chemical FormulaC7H7ClN2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 13 structure
13
吲达帕胺杂质13Indapamide Impurity 13
Indapamide Impurity 13
CAS No.22160-09-4
Chemical FormulaC9H11N
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 15 structure
15
吲达帕胺杂质15Indapamide Impurity 15
Indapamide Impurity 15
CAS No.1856658-28-0
Chemical FormulaC8H7ClO5S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 16 structure
16
吲达帕胺杂质16Indapamide Impurity 16
Indapamide Impurity 16
CAS No.53406-41-0
Chemical FormulaC9H10N2
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 17 structure
17
吲达帕胺杂质17Indapamide Impurity 17
Indapamide Impurity 17
CAS No.1918-13-4
Chemical FormulaC7H5Cl2NS
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 19 structure
19
吲达帕胺杂质19Indapamide Impurity 19
Indapamide Impurity 19
CAS No.1219174-77-2
Chemical FormulaC16H16ClN3O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 21 structure
21
吲达帕胺杂质21Indapamide Impurity 21
Indapamide Impurity 21
CAS No.604787-44-2
Chemical FormulaC9H9ClO5S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 25 structure
25
吲达帕胺杂质25Indapamide Impurity 25
Indapamide Impurity 25
CAS No.77083-53-5
Chemical FormulaC16H16ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 26 structure
26
吲达帕胺杂质26Indapamide Impurity 26
Indapamide Impurity 26
CAS No.77083-52-4
Chemical FormulaC16H16ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 27 structure
27
吲达帕胺杂质27Indapamide Impurity 27
Indapamide Impurity 27
CAS No.22160-13-0
Chemical FormulaC9H11N
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 31 structure
31
吲达帕胺杂质31Indapamide Impurity 31
Indapamide Impurity 31
CAS No.1353446-95-3
Chemical FormulaC18H18ClN3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 32 structure
32
吲达帕胺杂质32Indapamide Impurity 32
Indapamide Impurity 32
CAS No.1391053-97-6
Chemical FormulaC17H18ClN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 33 structure
33
吲达帕胺杂质33Indapamide Impurity 33
Indapamide Impurity 33
CAS No.2134930-52-0
Chemical FormulaC16H16ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 34 structure
34
吲达帕胺杂质34Indapamide Impurity 34
Indapamide Impurity 34
CAS No.83592-40-9
Chemical FormulaC17H18ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 35 structure
35
吲达帕胺杂质35Indapamide Impurity 35
Indapamide Impurity 35
CAS No.86052-24-6
Chemical FormulaC16H15Cl2N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 36 structure
36
吲达帕胺杂质36Indapamide Impurity 36
Indapamide Impurity 36
CAS No.86052-26-8
Chemical FormulaC16H15BrClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 37 structure
37
吲达帕胺杂质37Indapamide Impurity 37
Indapamide Impurity 37
CAS No.26807-66-9
Chemical FormulaC18H20ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 38 structure
38
吲达帕胺杂质38Indapamide Impurity 38
Indapamide Impurity 38
CAS No.127662-48-0
Chemical FormulaC17H18ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 39 structure
39
吲达帕胺杂质39Indapamide Impurity 39
Indapamide Impurity 39
CAS No.87445-50-9
Chemical FormulaC16H17ClN4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 40 structure
40
吲达帕胺杂质40Indapamide Impurity 40
Indapamide Impurity 40
CAS No.2469195-60-4
Chemical FormulaC16H16ClN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 41 structure
41
吲达帕胺杂质41Indapamide Impurity 41
Indapamide Impurity 41
CAS No.1005238-89-0
Chemical FormulaC16H16ClN3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 42 structure
42
吲达帕胺杂质42Indapamide Impurity 42
Indapamide Impurity 42
CAS No.75820-08-5
Chemical FormulaC16H16ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 43 structure
43
吲达帕胺杂质43Indapamide Impurity 43
Indapamide Impurity 43
CAS No.124810-16-8
Chemical FormulaC17H18ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 44 structure
44
吲达帕胺杂质44Indapamide Impurity 44
Indapamide Impurity 44
CAS No.87445-57-6
Chemical FormulaC16H18ClN5O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 45 structure
45
吲达帕胺杂质45Indapamide Impurity 45
Indapamide Impurity 45
CAS No.87445-48-5
Chemical FormulaC17H19ClN4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 46 structure
46
吲达帕胺杂质46Indapamide Impurity 46
Indapamide Impurity 46
CAS No.2247603-73-0
Chemical FormulaC17H18ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 47 structure
47
吲达帕胺杂质47Indapamide Impurity 47
Indapamide Impurity 47
CAS No.1151493-83-2
Chemical FormulaC16H14ClN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 48 structure
48
吲达帕胺杂质48Indapamide Impurity 48
Indapamide Impurity 48
CAS No.99291-18-6
Chemical FormulaC17H18ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 49 structure
49
吲达帕胺杂质49Indapamide Impurity 49
Indapamide Impurity 49
CAS No.127662-49-1
Chemical FormulaC17H18ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 50 structure
50
吲达帕胺杂质50Indapamide Impurity 50
Indapamide Impurity 50
CAS No.18502-95-9
Chemical FormulaC16H16ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 51 structure
51
吲达帕胺杂质51Indapamide Impurity 51
Indapamide Impurity 51
CAS No.99291-04-0
Chemical FormulaC17H18ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 52 structure
52
吲达帕胺杂质52Indapamide Impurity 52
Indapamide Impurity 52
CAS No.87445-58-7
Chemical FormulaC16H17ClN4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 53 structure
53
吲达帕胺杂质53Indapamide Impurity 53
Indapamide Impurity 53
CAS No.87445-54-3
Chemical FormulaC18H21ClN4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 54 structure
54
吲达帕胺杂质54Indapamide Impurity 54
Indapamide Impurity 54
CAS No.77856-16-7
Chemical FormulaC16H14ClN3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 55 structure
55
吲达帕胺杂质55Indapamide Impurity 55
Indapamide Impurity 55
CAS No.77856-15-6
Chemical FormulaC16H16ClN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 56 structure
56
吲达帕胺杂质56Indapamide Impurity 56
Indapamide Impurity 56
CAS No.87445-56-5
Chemical FormulaC18H19ClN4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 57 structure
57
吲达帕胺杂质57Indapamide Impurity 57
Indapamide Impurity 57
CAS No.26807-67-0
Chemical FormulaC21H24ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 58 structure
58
吲达帕胺杂质58Indapamide Impurity 58
Indapamide Impurity 58
CAS No.127678-18-6
Chemical FormulaC18H20ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 59 structure
59
吲达帕胺杂质59Indapamide Impurity 59
Indapamide Impurity 59
CAS No.127662-50-4
Chemical FormulaC18H20ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 60 structure
60
吲达帕胺杂质60Indapamide Impurity 60
Indapamide Impurity 60
CAS No.99291-19-7
Chemical FormulaC18H20ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 61 structure
61
吲达帕胺杂质61Indapamide Impurity 61
Indapamide Impurity 61
CAS No.2247603-75-2
Chemical FormulaC19H22ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 62 structure
62
吲达帕胺杂质62Indapamide Impurity 62
Indapamide Impurity 62
CAS No.1151493-79-6
Chemical FormulaC16H14ClN3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 63 structure
63
吲达帕胺杂质63Indapamide Impurity 63
Indapamide Impurity 63
CAS No.1353157-18-2
Chemical FormulaC18H18ClN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 64 structure
64
吲达帕胺杂质64Indapamide Impurity 64
Indapamide Impurity 64
CAS No.3011-89-0
Chemical FormulaC7H5ClN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 67 Monomer structure
67
吲达帕胺杂质67 单体Indapamide Impurity 67 Monomer
Indapamide Impurity 67 Monomer
CAS No.83435-66-9
Chemical FormulaC26H32N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 67 structure
67
吲达帕胺杂质67Indapamide Impurity 67
Indapamide Impurity 67
CAS No.83435-67-0
Chemical FormulaC26H32N2O5·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 68  (N-Nitroso Indapamide Impurity 67 Monomer) structure
68
吲达帕胺杂质68 (N-亚硝基吲达帕胺杂质67 单体)Indapamide Impurity 68 (N-Nitroso Indapamide Impurity 67 Monomer)
Indapamide Impurity 68 (N-Nitroso Indapamide Impurity 67 Monomer)
CAS No.1027955-20-9
Chemical FormulaC26H31N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 72 structure
72
吲达帕胺杂质72Indapamide Impurity 72
Indapamide Impurity 72
CAS No.890534-64-2
Chemical FormulaC11H13N
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 73 structure
73
吲达帕胺杂质73Indapamide Impurity 73
Indapamide Impurity 73
CAS No.890534-65-3
Chemical FormulaC11H11N
Purity>95%询价On request
10mg25mg50mg100mg
Indapamide Impurity 8-d3 structure
8-D3
吲达帕胺杂质8-d3Indapamide Impurity 8-d3
Indapamide Impurity 8-d3
CAS No.1246815-31-5
Chemical FormulaC9H8D3N
Purity>95%询价On request
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

吲达帕胺 —— 研究文献与合成路线Indapamide — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 吲达帕胺 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Indapamide. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stereoselective HPLC separation and configurational stability study of the N-nitrosamine impurity of indapamide
    Mammone FR, Panusa A, Pierini M, et al. · Journal of chromatography. A · 2026 · 被引 1cited 1
  2. Liquid chromatographic determination of indapamide in the presence of its degradation products
    Padval MV, Bhargava HN · Journal of pharmaceutical and biomedical analysis · 1993 · 被引 11cited 11
  3. A Deeper Investigation of Drug Degradation Mixtures Using a Combination of MS and NMR Data: Application to Indapamide
    Palaric C, Molinié R, Cailleu D, et al. · Molecules (Basel, Switzerland) · 2019 · 被引 4cited 4
  4. Development and validation of a stability-indicating assay method for simultaneous determination of perindopril and indapamide in combined dosage form by reversed-phase high-performance liquid chromatography
    Jogia H, Khandelwal U, Gandhi T, et al. · Journal of AOAC International · 2010 · 被引 9cited 9
  5. UHPLC-UV Method for Simultaneous Determination of Perindopril Arginine and Indapamide Hemihydrate in Combined Dosage Form: A Stability-Indicating Assay Method
    Al-Tannak NF · Scientia pharmaceutica · 2018 · 被引 6cited 6
  6. Delapril and Indapamide: Development and Validation of a Stability-Indicating Core-Shell LC Method and Its Application for Simultaneous Tablets Assay
    Gonçalves BR, Machado AKMS, Oliveira PR, et al. · Journal of AOAC International · 2018 · 被引 1cited 1

合成与制备工艺专利Synthesis & process patents

  1. Synthesis method of indapamide
    JIANG GENHUA HUO · 公开号 CN1927833CN1927833 · 2007
  2. Indapamide percutaneous controlled releast plaster and its preparation method
    FANG LIANG REN · 公开号 CN1823765CN1823765 · 2006
  3. Slow released indapamide microcapsule and its prepn process
    ZHANG XIAOMING · 公开号 CN1931161CN1931161 · 2007
  4. Indapamide drop pill and preparing method thereof
    QIAN JIN, XU JUN, PENG HONG · 公开号 CN1528295CN1528295 · 2004
  5. Compound pressure-reduction preparation containing indapamide and angiotensin converzyme inhibitor
    XU NANTU · 公开号 CN1524522CN1524522 · 2004

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

吲达帕胺 杂质谱研究要点Indapamide — impurity profiling notes

下面这些是拿到 吲达帕胺 的 60 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 60 impurity entries for Indapamide, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances